VICTOZA 1 PEN

Sku: 39047
30٫100 KD
بحجم: 1 PEN

غير متوفربالمخزون


Victoza® provided an additional benefit of greater weight loss in 2 head-to-head trials





Victoza® is not indicated for chronic weight management, and weight change was a secondary endpoint in clinical trials.


 



الوصف

التفاصيل

Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established CV disease.

معلومات اضافية

معلومات اضافية

العلامات التجارية

لا

الحجم

1 PEN

اتجاهات الاستخدام

Once a day, at any time, independent of meals. Victoza® does not require resuspension and can be injected in the abdomen, thigh, or upper arm with the NovoFine®

مكونات نشطة

liraglutide

إشارة

Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular (CV) events (

نوع الجلد

لا

استعراضات
Login/Sing-up to add a review